Eyeliss™ targets all three conditions by improving drainage, reducing capillary fragility and reducing irritation and skin slackening, while increasing skin firmness and elasticity.
Eyeliss™ is composed of three active substances hesperedin methyl, chalcone and two peptide chains. Peptides are small fragments of proteins, which are a vital part of the skin, and they affect collagen production and other vital skin functions. In a clinical study of 20 volunteers between 40 and 60 years old, who had chronic bags under their eyes, 65% showed a marked reduction in bags after just 28 days, and 70% showed measurable improvement after 56 days. The Electronic Retailing Self-Regulating Program (ERSP) recently investigated the claims made for Eyeliss™ and found them to be entirely justified. The ERSP did its own clinical trials of Eyeliss™ and a follow-up survey showed 62% of the volunteers believed the contours of the eyes were smoothed, 52% felt a reduction in the bags under the eyes, and 52% felt Eyeliss™ had a decongestant effect. Further, 86% of the subjects reported Eyeliss™ moisturized the skin, 71% felt their skin was softer after the trial, and 71% found Eyeliss™ to have a soothing effect.
Sam Dhatt, an award-winning anti-aging chemist, recommends Eyeliss should be included in all anti-aging eye products.